PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Search This Blog

Loading...

Friday, June 14, 2013

chakrabarty, hartranft, myriad

custom search

REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1654 Ex Parte Burkhard 10545676 - (D) PRATS 112(1)/102 WENDEROTH, LIND & PONACK, L.L.P. HA, JULIE

Tech Center 1700 Chemical & Materials Engineering
1734 Ex Parte Legario et al 10646930 - (D) Per Curiam 103 BERESKIN & PARR LLP/S.E.N.C.R.L., s.r.l. FELTON, AILEEN BAKER

Tech Center 2100 Computer Architecture and Software
2177 Ex Parte Merkel et al 10335110 - (D) DIXON 103 SAP / FINNEGAN, HENDERSON LLP RUTLEDGE, AMELIA L

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2443 Ex Parte Kihara et al 10861212 - (D) DIXON 103 FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP SHIN, KYUNG H

2476 Ex Parte CARDONA et al 11751302 - (D) CLEMENTS 103 IBM CORPORATION (MH) c/o MITCH HARRIS, ATTORNEY AT LAW, L.L.C. SLOMS, NICHOLAS

2675 Ex Parte Beretta 11017012 - (D) RUGGIERO 103 HEWLETT-PACKARD COMPANY MENBERU, BENIYAM

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3652 Ex Parte Kurita et al 11926720 - (D) BROWN 103 Applied Materials, Inc. LOWE, MICHAEL S

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3736 Ex Parte Calderon et al 12264293 - (D) FRANKLIN 103 DEKEL PATENT LTD. NGUYEN, HUONG Q

3736 Ex Parte Tenerz et al 10390185 - (D) NEW 103 FOLEY AND LARDNER LLP SMITH, FANGEMONIQUE A

3738 Ex Parte HARRIS et al 11626608 - (D) MILLS 102/103 Massachusetts General Hospital Perkins Cole LLP The General Hospital Corporation STEWART, JASON-DENNIS NEILKEN

3778 Ex Parte Cohen et al 11540418 - (D) HOFFMANN 102 KIMBERLY-CLARK WORLDWIDE, INC. ANDERSON, CATHARINE L

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1629 Ex Parte Miura et al 12067722 - (D) PRATS 103 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. TOWNSLEY, SARA ELIZABETH

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1629 Ex Parte Koenen et al 10515896 - (D) NEW 103 NATH, GOLDBERG & MEYER HUANG, GIGI GEORGIANA

Tech Center 1700 Chemical & Materials Engineering
1746 Ex Parte Reynolds et al 10363279 - (D) GARRIS 101/103 E I du Pont de Nemours & Company SCHATZ, CHRISTOPHER T

Tech Center 2100 Computer Architecture and Software
2113 Ex Parte Anerousis et al 10929878 - (D) HUME 102 RYAN, MASON & LEWIS, LLP MASKULINSKI, MICHAELC

2194 Ex Parte Cutlip 11847298 - (D) KUMAR 101/103 CAREY, RODRIGUEZ, GREENBERG & O'KEEFE, LLP TRUONG, LECHI

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3727 Ex Parte Mazur 11769810 - (D) BUNTING 103 Brinks Hofer Gilson & Lione/Ann Arbor SHAKERI, HADI

3769 Ex Parte Jung et al 11804304 - (D) PRATS 101/102/103 THE INVENTION SCIENCE FUND YAO, SAMCHUAN CUA  

REHEARING  

GRANTED
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3763 Ex Parte Beckham 11551339 - (D) GREEN obviousness-type double patenting Bard Peripheral Vascular, Inc. FLICK, JASON E

REEXAMINATION

AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1732 THE HAARTZ CORPORATION Requester and Respondent v. BENECKE-KALIKO AG Patent Owner and Appellant 95000611 6,663,738 09/829,196 LEBOVITZ 102/103 FAY SHARPE LLP Third Party Requester: GROSSMAN,TUCKER,PERREAULT & PFLEGER, PLLC DIAMOND, ALAN D original TENTONI, LEO B

1745 The Gillette Company Patent Owner and Appellant 90010769 6410187 09/393,043 LEBOVITZ 103 FISH & RICHARDSON P.C. Third Party Requester: Stites & Harbison PLLC original THE PROCTER & GAMBLE COMPANY LOPEZ, CARLOS N original CREPEAU, JONATHAN

FEDERAL CIRCUIT

REHEARING  

GRANTED
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3642 SOVERAIN SOFTWARE LLC, Plaintiff-Appellee, v. NEWEGG INC., Defendant-Appellant. 2011-1009 5,715,314 08/328,133 PER CURIAM claim interpretation STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. GREGORY, BERNARR E

SUPREME COURT  

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1632 ASSOCIATION FOR MOLECULAR PATHOLOGY, ET AL., PETITIONERS v. MYRIAD GENETICS, INC., ET AL. 12–398 5,747,282 08/483,554 5,693,473 08/480,784 5,837,492 08/639,501 THOMAS 101 101 ROTHWELL, FIGG, ERNST & MANBECK, P.C. RAZZAQUE, ABDUR; REES, DIANE; HAUDA, KAREN MARIE

This would be at odds with the very point of patents, which exist to promote creation. Diamond v. Chakrabarty, 447 U. S. 303, 309 (1980) (Products of nature are not created, and “‘manifestations . . . of nature [are] free to all men and reserved exclusively to none’”)....

In Chakrabarty, scientists added four plasmids to a bacterium, which enabled it to break down various components of crude oil. 447 U. S., at 305, and n. 1. The Court held that the modified bacterium was patentable. It explained that the patent claim was “not to a hitherto unknown natural phenomenon, but to a nonnaturally occurring manufacture or composition of matter—a product of human ingenuity ‘having a distinctive name, character [and] use.’” Id. , at 309–310 (quoting Hartranft v. Wiegmann, 121 U. S. 609, 615 (1887); alteration in original).

Diamond v. Chakrabarty, 447 U.S. 303, 206 USPQ 193 (1980) , 2103, 2105, 2106, 2107.01

We merely hold that genes and the information they encode are not patent eligible under §101 simply because they have been isolated from the surrounding genetic material.

No comments :